A detailed history of State Street Corp transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 13,917,111 shares of IRWD stock, worth $86.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,917,111
Previous 11,532,088 20.68%
Holding current value
$86.6 Million
Previous $132 Million 8.12%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$8.32 - $15.45 $19.8 Million - $36.8 Million
2,385,023 Added 20.68%
13,917,111 $121 Million
Q4 2023

Feb 14, 2024

SELL
$8.79 - $11.51 $4.09 Million - $5.35 Million
-464,777 Reduced 3.87%
11,532,088 $132 Million
Q3 2023

Nov 14, 2023

BUY
$8.25 - $11.35 $7.99 Million - $11 Million
968,376 Added 8.78%
11,996,865 $116 Million
Q2 2023

Aug 14, 2023

BUY
$10.1 - $11.6 $5.52 Million - $6.34 Million
546,647 Added 5.22%
11,028,489 $117 Million
Q1 2023

May 15, 2023

SELL
$10.37 - $12.56 $7.24 Million - $8.76 Million
-697,736 Reduced 6.24%
10,481,842 $110 Million
Q4 2022

Feb 14, 2023

SELL
$9.9 - $12.43 $2.72 Million - $3.41 Million
-274,592 Reduced 2.4%
11,179,578 $139 Million
Q3 2022

Nov 15, 2022

BUY
$10.14 - $12.38 $5.75 Million - $7.02 Million
567,365 Added 5.21%
11,454,170 $119 Million
Q2 2022

Aug 15, 2022

BUY
$11.05 - $12.72 $28.6 Million - $32.9 Million
2,589,738 Added 31.21%
10,886,805 $126 Million
Q1 2022

May 16, 2022

BUY
$10.61 - $12.88 $4.44 Million - $5.39 Million
418,756 Added 5.32%
8,297,067 $104 Million
Q4 2021

Feb 14, 2022

BUY
$10.86 - $13.95 $4.84 Million - $6.21 Million
445,302 Added 5.99%
7,878,311 $91.9 Million
Q3 2021

Nov 15, 2021

BUY
$11.92 - $13.92 $7.48 Million - $8.73 Million
627,340 Added 9.22%
7,433,009 $97.1 Million
Q2 2021

Aug 16, 2021

SELL
$10.16 - $13.11 $5.84 Million - $7.53 Million
-574,357 Reduced 7.78%
6,805,669 $87.6 Million
Q1 2021

May 17, 2021

SELL
$9.04 - $11.86 $1.85 Million - $2.42 Million
-204,343 Reduced 2.69%
7,380,026 $82.5 Million
Q4 2020

Feb 16, 2021

SELL
$9.05 - $12.2 $3.62 Million - $4.88 Million
-399,881 Reduced 5.01%
7,584,369 $86.4 Million
Q3 2020

Nov 10, 2020

SELL
$8.99 - $10.74 $2.25 Million - $2.69 Million
-250,313 Reduced 3.04%
7,984,250 $71.8 Million
Q2 2020

Aug 14, 2020

BUY
$9.14 - $11.97 $21.8 Million - $28.5 Million
2,381,926 Added 40.7%
8,234,563 $85 Million
Q1 2020

May 11, 2020

BUY
$8.58 - $14.01 $50.2 Million - $82 Million
5,852,637 New
5,852,637 $59.1 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $953M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.